Kevin D. Freeman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Keller, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Jack W. Callicutt, by power of attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Kevin D. Freeman

Form 4 holding Director

GALECTIN THERAPEUTICS INC

Security class
Common Stock
Shares / value
80,000
Estimated value
$460,800
Report date
23 Dec 2025
Price
$5.76
Ownership
By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC

Insider Reports Filed by Kevin D. Freeman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .